Smarter Team

About the Author Smarter Team

Smarter Analyst was established to fill a gap in financial reporting for sell-side investors, where they can read exclusive reports in real time. Smarter Analyst provides coverage of equities research, unique analyst insights, and outstanding articles from knowledgeable contributors, in addition to the latest stock market news, all hand-picked by our editors.

Does This Analyst Make a Good Case for Matheson Analytics Inc (HMNY)?

For much of its lifetime as a public company, the stock chart of IT consulting solutions firm Helios and Matheson Analytics Inc (NASDAQ:HMNY) …

Guggenheim Storms Into the Dermatology Space; Initiates Buy on Revance Therapeutics, Inc. (RVNC)

Guggenheim analyst Rohit Vanjani has initiated coverage of the dermatology space, announcing ratings on four pharmaceuticals stocks. We don’t have time to cover …

Raymond James Sings the Praises of Adamis Pharmaceuticals; Here’s Why

What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur is out today with a bullish note on …

Investing Guru Jim Simons Rolls Out the Red Carpet for Valeant Pharmaceuticals, Cuts Opko Health

Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing out on controversial healthcare stock Valeant Pharmaceuticals (NYSE:VRX). …

Bluebird Bio (BLUE) Bullish Camp Just Got Stronger

Bluebird Bio Inc (NASDAQ:BLUE) just attracted another bull to its biotech table, with Canaccord analyst John Newman believing the company’s collaboration with Celgene …

Himax Is Not Looking Too Hot for 2018, Says Rosenblatt

Himax Technologies (NASDAQ:HIMX) is a semiconductor company that may have met its match: lackluster 3D sensing revenue just around the corner. Rosenblatt analyst …

Pyxis Tankers Inc. (PXS) Downgraded After Reaching $9 Due to Expensive Valuation

Analyst James Jang and his team cut their rating on Pyxis Tankers Inc (NASDAQ:PXS) from Buy to Hold, with a $3.00 price target.

Is Valeant Cured of Headwinds? Analyst Sheds Light Following Meeting with Management

Valeant Pharmaceuticals (NYSE:VRX) management boiled down its position to BTIG analyst Tim Chiang, where the discussion gravitated on the standing of the company’s …

Here’s Why OHR Pharmaceutical Inc (OHRP) Shares Jumped Today

An article was published on Seeking Alpha detailing a long position.

Oppenheimer Bullish on Nutanix’s Transition; Boosts Price-Target

Nutanix Inc. (NASDAQ:NTNX) keeps producing earnings results that blow away Wall Street estimates, says Oppenheimer analyst Ittai Kidron in raising his price target on …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts